|
FDA Warns Cold Sore Drugmaker as Review of OTC Skin Protectants Continues
The FDA has warned Quadex Pharmaceuticals that its cold sore treatment Viroxyn Professional was never approved as a new drug and does not conform to the formulation and labeling requirements for an OTC cold sore drug.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives